Advancing Structure Elucidation with a Flexible Multi‐Spectral AI Model

M Martin Priessner (Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden) R Richard J. Lewis I Isak Lemurell (Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden) M Magnus J. Johansson (Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden) J JonathanM. Goodman (Centre for Molecular Informatics Yusuf Hamied Department of Chemistry University of Cambridge Lensfield Road Cambridge CB2 1EW UK) J Jon Paul Janet A Anna Tomberg (Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden)

Abstract

Abstract Validating chemical synthesis success requires confirming the desired product using various analytical techniques. While spectroscopic data collection is increasingly automated, interpreting results remains a major bottleneck, often requiring expert input. With advances in laboratory automation and high‐throughput synthesis, this challenge is expected to intensify. We introduce the MultiModalSpectralTransformer (MMST), a machine learning method that predicts chemical structures directly from diverse spectral data (NMR, IR, and MS). Trained on 4 million simulated compounds, MMST achieves 72% and 80% as top‐1 and top‐3 accuracy, respectively. To address out‐of‐distribution challenges, we implemented an active learning improvement cycle that generates molecules in similar chemical spaces, enabling the model to adapt to chemical structures beyond its original training data. We demonstrate MMST's capabilities through comprehensive benchmarking across diverse molecular weight ranges and chemical spaces. Notably, despite training solely on simulated data, MMST demonstrates good performance with experimental spectra. This research represents a significant advancement in automated structure elucidation, offering a powerful and adaptable tool that bridges the gap between simulated and real‐world data.

Article Details

Volume / Issue Vol. 65, Issue 2
Published January 09, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (7)

M

Martin Priessner

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden

R

Richard J. Lewis

I

Isak Lemurell

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden

M

Magnus J. Johansson

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden

J

JonathanM. Goodman

Centre for Molecular Informatics Yusuf Hamied Department of Chemistry University of Cambridge Lensfield Road Cambridge CB2 1EW UK

J

Jon Paul Janet

A

Anna Tomberg

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Pepparedsleden 1 Mölndal 43183 Sweden